Search results
The polio vaccine developed by Dr. Salk and colleagues is licensed in the U.S. Before the polio vaccine, the disease had been a major cause of disability in children. About 16,000 cases of polio (paralytic poliomyelitis) occurred each year in the U.S. in the 20th century compared with none in 2020.
In 1957, Jonas Salk, developer of the first safe and effective polio vaccine, began his quest to fulfill his second dream: create a collaborative environment where researchers could explore the basic principles of life and contemplate the wider implications of their discoveries for the future of humanity.
9 lut 2010 · On March 26, 1953, American medical researcher Dr. Jonas Salk announces on a national radio show that he has successfully tested a vaccine against poliomyelitis, the virus that causes the...
The vaccine, they said, was 80-90% effective against paralytic polio. The U.S. government licensed Salk’s vaccine later this same day. The press conference and licensure paved the way for widespread distribution and use of the vaccine.
18 wrz 2024 · Jonas Salk (October 28, 1914 - June 23, 1995) was an American medical researcher celebrated for his pioneering work in virology, particularly the development of the first successful polio vaccine. This review highlights Salk's multifaceted talent and contributions.
Jonas Salk (1914–1995) became a national hero when he allayed the fear of the dreaded disease with his polio vaccine, approved in 1955. Although it was the first polio vaccine, it was not to be the last; Albert Bruce Sabin (1906–1993) introduced an oral vaccine in the United States in the 1960s that replaced Salk’s.
Contrary to the era’s prevailing scientific opinion, Salk believed his vaccine, composed of “killed” polio virus, could immunize without risk of infecting the patient. Salk administered the vaccine to volunteers who had not had polio, including himself, his lab scientist, his wife and their children.
